To continue or not to continue? Antipsychotic medication maintenance versus dose-reduction/discontinuation in first episode psychosis: HAMLETT, a pragmatic multicenter single-blind randomized controlled trial

Marieke J.H. Begemann*, Ilse A. Thompson, Wim Veling, Shiral S. Gangadin, Chris N.W. Geraets, Erna Van 'T Hag, Sanne J. Müller-Kuperus, Priscilla P. Oomen, Alban E. Voppel, Mark Van Der Gaag, Martijn J. Kikkert, Jim Van Os, H. Filip E. Smit, Rikus H. Knegtering, Sybren Wiersma, Luyken H. Stouten, Harm J. Gijsman, Lex Wunderink, Anton B.P. Staring, Selene R.T. VeermanAmrita G.S. Mahabir, Jörg Kurkamp, Gerdina H.M. Pijnenborg, Natalie D. Veen, Machteld Marcelis, Koen P. Grootens, Gunnar Faber, Nico J. Van Beveren, Agaath Been, Truus Van Den Brink, Maarten Bak, Therese A.M.J. Van Amelsvoort, Andrea Ruissen, Christine Blanke, Karin Groen, Lieuwe De Haan, Iris E.C. Sommer

*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

15 Downloads (Pure)

Fingerprint

Dive into the research topics of 'To continue or not to continue? Antipsychotic medication maintenance versus dose-reduction/discontinuation in first episode psychosis: HAMLETT, a pragmatic multicenter single-blind randomized controlled trial'. Together they form a unique fingerprint.

Medicine and Dentistry